Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update for SHR0302 assessing efficacy and safety in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR0302 (SHR0302)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED